Mathematical modeling of cancer immunotherapy for personalized clinical translation
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2022/12/19
-
Journal
-
Indian UGC (journal)
-
Refrences123
-
Citations9
-
Joseph D. Butner ORCID (unauthenticated)
-
Prashant Dogra ORCID (unauthenticated)
-
Caroline Chung
-
Renata Pasqualini
-
Wadih Arap
-
John Lowengrub
-
Vittorio Cristini
-
Zhihui Wang ORCID (unauthenticated)
Cite
Butner, Joseph D., et al. “Mathematical Modeling of Cancer Immunotherapy for Personalized Clinical Translation”. Nature Computational Science, vol. 2, no. 12, 2022, pp. 785-96, https://doi.org/10.1038/s43588-022-00377-z.
Butner, J. D., Dogra, P., Chung, C., Pasqualini, R., Arap, W., Lowengrub, J., Cristini, V., & Wang, Z. (2022). Mathematical modeling of cancer immunotherapy for personalized clinical translation. Nature Computational Science, 2(12), 785-796. https://doi.org/10.1038/s43588-022-00377-z
Butner, Joseph D., Prashant Dogra, Caroline Chung, Renata Pasqualini, Wadih Arap, John Lowengrub, Vittorio Cristini, and Zhihui Wang. “Mathematical Modeling of Cancer Immunotherapy for Personalized Clinical Translation”. Nature Computational Science 2, no. 12 (2022): 785-96. https://doi.org/10.1038/s43588-022-00377-z.
Butner JD, Dogra P, Chung C, Pasqualini R, Arap W, Lowengrub J, et al. Mathematical modeling of cancer immunotherapy for personalized clinical translation. Nature Computational Science. 2022;2(12):785-96.
Journal Categories
Science
Mathematics
Instruments and machines
Electronic computers
Computer science
Science
Science (General)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| T cell therapy against cancer: A predictive diffuse-interface mathematical model informed by pre-clinical studies | Journal of Theoretical Biology |
| 4 | 2022 |
| Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy | Journal of Controlled Release |
| 26 | 2022 |
| Mathematical Modeling to Simulate the Effect of Adding Radiation Therapy to Immunotherapy and Application to Hepatocellular Carcinoma | International Journal of Radiation Oncology*Biology*Physics |
| 17 | 2022 |
| 10.1109/JPROC.2021.3136715 | Proceedings of the IEEE |
| 2022 | |
Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer | Pharmaceutical Research |
| 8 | 2022 |
Refrences Analysis
The category
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens 47
is the most frequently represented among the references in this article. It primarily includes studies from Cancer Research and Nature Reviews Cancer. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Mathematical modeling and bifurcation analysis for a biological mechanism of cancer drug resistance | Acta Mathematica Scientia |
| 2024 | |
| A multi-objective optimization framework for determining optimal chemotherapy dosing and treatment duration | Healthcare Analytics | 2024 | ||
Dose optimization of an adjuvanted peptide-based personalized neoantigen melanoma vaccine | PLOS Computational Biology |
| 2024 | |
Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy | Frontiers in Immunology |
| 2024 | |
Continuum Robots and Magnetic Soft Robots: From Models to Interdisciplinary Challenges for Medical Applications | Micromachines |
| 2024 |
Citations Analysis
The category
Science: Biology (General) 4
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Mathematical Modeling Support for Lung Cancer Therapy—A Short Review and was published in 2023. The most recent citation comes from a 2024 study titled Designing combination therapies for cancer treatment: application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy. This article reached its peak citation in 2024, with 5 citations. It has been cited in 9 different journals, 55% of which are open access. Among related journals, the Frontiers in Immunology cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.